Redirecting to https://newsroom.astellas.us/2018-07-13-U-S-FDA-Approves-XTANDI-R-enzalutamide-for-the-Treatment-of-Men-with-Non-Metastatic-Castration-Resistant-Prostate-Cancer-CRPC...

Click here if your browser doesn't automatically take you to this page.